Follow-up documentation. Uveitis characteristics | Group I. Uveitis, ANA-positive, no JIA, N = 56 | Group II. Uveitis manifestation after JIA disease onset*, N = 56 | Group III. Uveitis manifestation before JIA disease onset*, N = 37 | p value†| Significant pairwise comparisons‡ | ||||||
---|---|---|---|---|---|---|---|---|---|---|---|
 | N (%) | Mean | SD | N (%) | Mean | SD | N (%) | Mean | SD |  |  |
Duration of uveitis onset until follow-up documentation, months | 56 | 20.2 | 23.1 | 56 | 20.2 | 23.1 | 37 | 19.7 | 18.0 | 0.992 | – |
Unilateral uveitis, n (%), data provided in 110 cases | 11 (27.5) | n.a. | n.a. | 25 (61.0) | n.a. | n.a. | 13 (44.8) | n.a. | n.a. | 0.035 | I vs. II |
Bilateral uveitis, n (%), data provided in 110 cases | 29 (72.5) | n.a. | n.a. | 16 (39.0) | n.a. | n.a. | 14 (55.2) | n.a. | n.a. | Â | Â |
Inactive uveitis (AC cell grade < 0.5+); n (%), data provided in 74 cases | 22 (64.7) | n.a. | n.a. | 15 (55.8) | n.a. | n.a. | 8 (61.5) | n.a. | n.a. | 0.854 | – |
Visual acuity in uveitis eyes, logMAR | 64 | 0.28 | 0.31 | 53 | 0.24 | 0.41 | 37 | 0.38 | 0.51 | 0.152 | – |
Worse eyes, logMAR | 52 | 0.31 | 0.46 | 53 | 0.29 | 0.52 | 33 | 0.47 | 0.58 | 0.038 | I vs. III, II vs. III |